Efficacy of an hypericum perforatum (St. John's Wort) extract in preventing and reverting a condition of escape deficit in rats

Neuropsychopharmacology

Volumn 21, Issue 2, 1999, Pages 247-257

  Gambarana, Carla ^a   Ghiglieri, Ombretta ^a   Tolu, Pierluigi ^a   De Montis, M Graziella ^a   Giachetti, Daniela ^a   Bombardelli, Ezio ^b   Tagliamonte, Alessandro ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b INDENA S P A   (Italy)

Author keywords

Anhedonia; Depression; Escape deficit; Fluoxetine; Hypericum perforatum; Imipramine; Rat

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; FLUOXETINE; IMIPRAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; APPETITE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; ESCAPE BEHAVIOR; HYPERICUM PERFORATUM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REINFORCEMENT; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION; TRAINING;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ACUTE DISEASE; ANIMALS; APPETITE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ELECTROSHOCK; ESCAPE REACTION; FLUOXETINE; IMIPRAMINE; MALE; MOTOR ACTIVITY; PAIN; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; THEALES;

EID: 0033013398     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00027-5     Document Type: Article

References (32)

1. Bombardelli E., Morazzoni P. Hypericum perforatum. Fitoterapia. 66:1995;43-68.
2. Butterweck V., Wall A., Liefländer-Wulf U., Winterhoff H., Nahrstedt A. Effects of the total extract and fractions of hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry. 30(Suppl):1997;117-124.
3. Chatterjee S.S., Bhattacharya S.K., Wonnemann M., Singer A., Müller W.E. Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci. 63:1998;499-510.
4. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J Pharmacol Exp Ther. 72:1941;74-79.
5. De Montis M.G., Gambarana C., Ghiglieri O., Tagliamonte A. Reversal of stable behavioural modifications through NMDA receptor inhibition in rats. Behav Pharmacol. 6:1995;562-567.
6. De Smet P.A.G.M., Nolen W.A. St John's wort as an antidepressant. Brit Med J. 313:1996;241-242.
7. 1A receptor antagonists. Psychopharmacology. 119:1995;47-54.
8. Duke J.A. Handbook of Medicinal Herbs. 1985;CRC Press, Boca Raton, Florida. , pp 242-243.
9. Eddy N.B., Leimbach D. Synthetic analgesics. II Diethinylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther. 107:1953;385-393.
10. Erdelmeier C.A.J. Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmacopsychiatry. 31:1998;2-6.
11. Ernst E. St. John's wort, an antidepressant? A systematic, criteria-based review. Phytomedicine. 2:1995;67-71.
12. 1A receptor antagonist, WAY100635. Eur J Pharmacol. 281:1995;81-88.
13. Gambarana C., Ghiglieri O., Taddei I., Tagliamonte A., De Montis M.G. Imipramine and fluoxetine prevent the stress-induced escape deficits in rats through a distinct mechanism of action. Behav Pharmacol. 6:1995;66-73. a.
14. 1 dopamine receptors in mediating the antidepressant effect of imipramine. Pharmacol Biochem Behav. 50:1995;147-151. b.
15. 1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine. Prog Neuro-Psychopharmacol Biol Psychiat. 19:1995;741-755. c.
16. Ghiglieri O., Gambarana C., Scheggi S., Tagliamonte A., Willner P., De Montis M.G. Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress. Behav Pharmacol. 8:1997;619-628.
17. 1A receptors. Pharmacological, biochemical, functional and regulatory properties Whitaker-Azmitia P.M., Peroutka S.J. The Neuropharmacology of Serotonin. 1990;114-129 New York Academy of Science, New York, NY.
18. Laakmann G., Schüle C., Baghai T., Kieser M. St. John's wort in mild to moderate depression. the relevance of hyperforin for the clinical efficacy Pharmacopsychiatry. 31(Suppl):1998;54-59.
19. Linde K., Ramirez G., Mulrow C.D., Pauls A., Weidenhammer W., Melchart D. St John's wort for depression - an overview and meta-analysis of randomised clinical trials. Brit Med J. 313:1996;253-258.
20. 1B receptor. Whitaker-Azmitia P.M., Peroutka S.J. The Neuropharmacology of Serotonin. 1990;132-147 New York Academy of Science, New York, NY.
21. Müller W.E., Rolli M., Schäfer C., Hafner U. Effects of Hypericum extract (Li160) in biochemicals models of antidepressant activity. Pharmacopsychiatry. 30(Suppl 2):1997;102-107.
22. Müller W.E., Singer A., Wonnemann M., Hafner U., Rolli M., Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry. 31(Suppl 1):1998;16-21.
23. Nahrstedt A., Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry. 30(Suppl 2):1997;129-134.
24. Okpanyi S.N., Weischer M.L. Tierexperimentelle Untersuchengen zur psychotropen Wirksamkeit eines Hypericum-Extraktes. Arzneimittelforschung. 37:1987;10-13.
25. Overmier J.B., Seligman M.E.P. Effects of inescapable shock upon subsequent escape and avoidance learning. J Comp Physiol Psychol. 63:1967;23-33.
26. Seligman M.E.P., Maier S.F. Failure to escape traumatic shock. J Exp Psychol. 74:1967;1-9.
27. 1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Res. 527:1990;234-243.
28. Sherman A.D., Sacquitine J.L., Petty F. Specificity of the learned helplessnes model of depression. Pharmacol Biochem Behav. 16:1982;449-454.
29. 1A selective agonists. Eur J Pharmacol. 125:1986;295-298.
30. Volz H.P. Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry. 30(Suppl.):1997;72-77.
31. Winterhoff H., Butterweck V., Nahrstedt A., Gumbinger H.G., Schulz V., Erping S., Boáhammer F., Wieligmann A. Pharmakologische Untersuchungen zur antidepressiven Wirkung von Hypericum perforatum L. Loew D., Rietbroek N. Phytopharmaka in Forschung und klinischer Anwendung. 1995;39-56 Darmstadt, Steinkopff Verlag.
32. Woolfe G., McDonald A.D. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther. 80:1944;300-307.